Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Int J Mol Sci. 2023 Jan 21;24(3):2133. doi: 10.3390/ijms24032133.
In the last few decades, the prevalence of diabetes mellitus (DM) has increased rapidly. Diabetic kidney disease (DKD) is the major cause of end-stage renal disease (ESRD) globally, attributed to hemodynamic changes and chronic hyperglycemia. Recent findings have emphasized the role of cell-cycle dysregulation in renal fibrosis and ESRD. Under normal physiological conditions, most mature renal cells are arrested in the G0 phase of the cell cycle, with a rather low rate of renewal. However, renal cells can bypass restriction points and re-enter the cell cycle under stimulation of injuries induced via metabolic disorders. Mild injuries activate proliferation of renal cells to compensate for cell loss and reinstate renal function, while severe or repeated injuries will lead to DNA damage and maladaptive repair which ultimately results in cell-cycle arrest or overproliferation, and eventually promote renal fibrosis and ESRD. In this review, we focus on the role of cell-cycle dysregulation in DKD and discuss new, emerging pathways that are implicated in the process.
在过去几十年中,糖尿病的患病率迅速增加。糖尿病肾病(DKD)是全球范围内导致终末期肾病(ESRD)的主要原因,这归因于血液动力学改变和慢性高血糖。最近的研究结果强调了细胞周期失调在肾纤维化和 ESRD 中的作用。在正常生理条件下,大多数成熟的肾细胞停滞在细胞周期的 G0 期,更新率相当低。然而,在代谢紊乱引起的损伤刺激下,肾细胞可以绕过限制点并重新进入细胞周期。轻度损伤会激活肾细胞的增殖,以补偿细胞丢失并恢复肾功能,而严重或反复的损伤会导致 DNA 损伤和适应性修复,最终导致细胞周期停滞或过度增殖,并最终促进肾纤维化和 ESRD。在这篇综述中,我们重点关注细胞周期失调在 DKD 中的作用,并讨论了新的、新兴的与该过程相关的途径。